# Entos Pharmaceuticals Inc. — Form D

Entos Pharmaceuticals Inc. of EDMONTON, A0, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-26. The offering totals $4.0M, of which $100K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-05-26
- Form: D
- Accession: 0001567619-20-011158
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $4.0M
- Amount sold: $100K
- Remaining: $3.9M
- Investors: 1
- Date of first sale: 2020-05-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367695

## Issuer

- Name: Entos Pharmaceuticals Inc.
- CIK: 0001812824
- Entity type: Corporation
- Jurisdiction: ALBERTA, CANADA
- Incorporated: 2016
- Address: 2500-10220 103 AVE NW, EDMONTON, A0, T5J 0K4
- Phone: 780-862-7445

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Roy Duncan | Director | Edmonton, A0 |
| Andries Zijlstra | Director | Edmonton, A0 |
| John Lewis | Executive Officer | Gibsonia, PA |
| Arun Raturi | Executive Officer | Edmonton, A0 |

## More

- [CIK 1812824 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1812824&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-20-011158.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.